A fecal incontinence test has won regulatory approval, announced the company that originally licensed the technology from the Mayo Clinic in 2009. Medspira, based in Minneapolis, said the U.S. Food and Drug Administration has approved its mcompassanorectal manometry device that can evaluate how the pelvic floor of a person with constipation or fecal incontinence functions. The system comprises three components: adisposable catheter, mobile tablet PC and wireless portable manometer. The test can be conducted by even inexperienced users, noted the company in a news release, and results are displayed on the tablet PC in real time. The fully secure data can be emailed to specialists for review and interpretation.
